205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.89%
Negative revenue growth while MU stands at 10.28%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.13%
Negative gross profit growth while MU is at 19.28%. Joel Greenblatt would examine cost competitiveness or demand decline.
-13.11%
Negative EBIT growth while MU is at 27.46%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.58%
Negative operating income growth while MU is at 27.46%. Joel Greenblatt would press for urgent turnaround measures.
-73.23%
Negative net income growth while MU stands at 43.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-72.87%
Negative EPS growth while MU is at 42.95%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-73.02%
Negative diluted EPS growth while MU is at 42.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.30%
Share reduction while MU is at 0.27%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.10%
Reduced diluted shares while MU is at 0.85%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
23.81%
Dividend growth of 23.81% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
12.02%
OCF growth under 50% of MU's 33.07%. Michael Burry might suspect questionable revenue recognition or rising costs.
10.55%
FCF growth under 50% of MU's 47.63%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
46.89%
10Y revenue/share CAGR under 50% of MU's 196.53%. Michael Burry would suspect a lasting competitive disadvantage.
42.24%
5Y revenue/share CAGR under 50% of MU's 185.42%. Michael Burry would suspect a significant competitive gap or product weakness.
21.89%
3Y revenue/share CAGR at 50-75% of MU's 39.84%. Martin Whitman would question if the firm lags behind competitor innovations.
88.82%
10Y OCF/share CAGR under 50% of MU's 1444.18%. Michael Burry would worry about a persistent underperformance in cash creation.
100.89%
Below 50% of MU's 549.71%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
61.14%
3Y OCF/share CAGR under 50% of MU's 129.00%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-36.54%
Negative 10Y net income/share CAGR while MU is at 1140.46%. Joel Greenblatt sees a major red flag in long-term profit erosion.
47.24%
Below 50% of MU's 989.51%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-55.69%
Negative 3Y CAGR while MU is 98.30%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.34%
10Y equity/share CAGR at 50-75% of MU's 66.76%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
6.56%
Below 50% of MU's 120.74%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.71%
Below 50% of MU's 66.49%. Michael Burry suspects a serious short-term disadvantage in building book value.
516.71%
Dividend/share CAGR of 516.71% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.79%
Dividend/share CAGR of 193.79% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.37%
3Y dividend/share CAGR of 82.37% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-18.91%
Firm’s AR is declining while MU shows 7.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.57%
Inventory growth well above MU's 1.93%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.21%
Asset growth at 50-75% of MU's 6.22%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-5.64%
We have a declining book value while MU shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.79%
We have some new debt while MU reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.93%
R&D growth drastically higher vs. MU's 3.00%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.73%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.